The Javelin peripheral IVL catheter. [Image courtesy of Johnson & Johnson MedTech/Shockwave Medical] Johnson & Johnson MedTech‘s Shockwave Medical unit today announced the first clinical ...

An initial strategy of catheter ablation leads to a lower risk for a composite primary end point than antiarrhythmic drug ...

Catheter related problems due to an indwelling urinary catheter (IUC) have existed as long as urinary catheters have been utilized. This section will review IUC complications: infectious complications ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

The Varipulse catheter (Johnson & Johnson) Varipulse picked up a CE mark in Europe and an approval in Japan at the top of this year. J&J has estimated that afib—the most common heart arrhythmia ...

Shockwave’s Javelin catheter met prespecified safety and effectiveness goals at 30 days. Credit: A Lot Of People via Shutterstock. Johnson & Johnson’s (J&J) Shockwave Medical unit has reported that ...

Medtronic, Boston Scientific and other medtech leaders are competing to commercialize catheter technology with roots in ...